Indian clinical practice consensus guidelines for the management of oral cavity cancer: Update 2022
Year: 2024
Type: article
Abstract: The treatment of oral cavity cancer primarily depends on the location, tumor size, and feasibility of organ preservation in patients with negative margins. A liquid biopsy is a minimally invasive approach for detecting blood-based signatures such as circulating tumor cells (CTCs) and circulatory tumor DNA (ctDNA). To assess the presence of occult metastatic disease, sentinel lymph node biopsy (SLNB) is recommended in early-stage oral cavity cancer (OCC). In India, surgery is the preferred choice of treatment for oral cancers. Selected patients, who are medically inoperable or refuse surgery, should be given definitive radiotherapy (RT) as an alternative to surgery. Concurrent chemoradiation (CCRT) may be considered an alternative option to definitive RT in patients with unresectable oral cancer.
Authors: Pankaj Chaturvedi, Kumar Prabhash, K Govind Babu, Moni Kuriakose, Praveen Birur, Anil K. Anand, Ashish Kaushal, Abhishek Mahajan, Judita Syiemlieh, Manish Singhal, Munish Gairola, Prakash Ramachandra, Sumit Goyal, Subashini John, Rohit Nayyar, Vijay M Patil, Vishal Rao, Vanita Noronha, Vikas Roshan, G.K. Rath
Institutions: Tata Memorial Hospital, HCG Cancer Hospital, Healthcare Global Enterprises, Mazumdar Shaw Medical Centre, Fortis Memorial Research Institute, Clatterbridge Cancer Centre NHS Foundation Trust, Indraprastha Apollo Hospitals, Rajiv Gandhi Cancer Institute and Research Centre, Sri Shankara Cancer Hospital and Research Center, Christian Medical College, Vellore, Max Super Speciality Hospital, P. D. Hinduja Hospital and Medical Research Centre, HCG Cancer Centre, All India Institute of Medical Sciences
Language: English
Topic: Head and Neck Cancer Studies
Subfield: Otorhinolaryngology
Field: Medicine
Domain: Health Sciences
Open Access status: diamond
OpenAlex ID: W4390919894